PPARG and hepatocellular carcinoma: Interestingly, in line with the deleterious role of PPARγ in HCC, Xiong et al. recently showed that PPARγ signaling promotes resistance to checkpoint inhibitors via induction of VEGFA transcription, which drives an immunosuppressive environment with myeloid-derived suppressor cell expansion and CD8 T cell dysfunction [64].